Pharma-Europe SRL
3.7 FTEPharma-Europe reported total assets of €4.72m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 3.7 full-time equivalents.
The score of Pharma-Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +70 % Total assets +109 % Headcount (avg FTE) +85 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma-Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Pharma-Europe's financial analysis
- Solvency56.9%sector median: 39.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma-Europe
Pharma-Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0645.778.092
- VAT number
- BE0645778092
- Peppol
- Registered · 0208:0645778092 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jan 2016
- Registered office
- 1340 Ottignies-Louvain-la-Neuve
- Size
- Micro · 3.7 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery (NACE 46150)
Pharma-Europe (SRL) has been based in Ottignies-Louvain-la-Neuve since 2016, active in: activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery. For 2025, it reports a net profit of €1.14m and equity of €2.69m; its revenue is not published. With 3.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 56.9%, above the median of its sector (39.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma-Europe
Companies in the same business, of comparable size and area, outside its group.
- Medenvision Manufacture of medical and dental instruments and supplies Westerlo · balance sheet €11.3m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- Cole Pharmaceuticals Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet €1.51m
- Eurosets Benelux Activities of agents involved in non-specialised wholesale Wavre · balance sheet €1.16m
- Precision Dynamics Europe Activities of agents involved in non-specialised wholesale Nivelles · balance sheet €3.79m
- Bescan Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet 528,845 €
- Loupi Medical Belgium Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet 440,359 €
- APIX Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Mont-Saint-Guibert · balance sheet 121,707 €
Frequently asked questions about Pharma-Europe
What is the revenue of Pharma-Europe?
Pharma-Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma-Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0645778092 for Pharma-Europe, if the company is VAT-registered. Its company number (CBE) is 0645.778.092.
Where is the registered office of Pharma-Europe?
According to the CBE register, the registered office of Pharma-Europe is in 1340 Ottignies-Louvain-la-Neuve.
What is the equity of Pharma-Europe?
At the close of the 2025 financial year, the equity of Pharma-Europe amounts to 2,689,281 €, a solvency of 56.9% of total assets.
How many people work at Pharma-Europe?
3.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma-Europe?
The register lists 2 active mandates at Pharma-Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma-Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →